Hainan Huluwa Pharmaceutical Group Co Ltd - ESG Rating & Company Profile powered by AI
The ESG rating includes 17 UN Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Life on Land'. The assessment of Hainan Huluwa Pharmaceutical Group Co Ltd uses intelligence from across the web as well as from available documents by Hainan Huluwa Pharmaceutical Group Co Ltd. The dashboard includes a Q&A table about Hainan Huluwa Pharmaceutical Group Co Ltd.
Hainan Huluwa Pharmaceutical Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Hainan Huluwa Pharmaceutical Group Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Hainan Huluwa Pharmaceutical Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose current and historical energy intensity?
Does Hainan Huluwa Pharmaceutical Group Co Ltd report the average age of the workforce?
Does Hainan Huluwa Pharmaceutical Group Co Ltd reference operational or capital allocation in relation to climate change?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose its ethnicity pay gap?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose cybersecurity risks?
Does Hainan Huluwa Pharmaceutical Group Co Ltd offer flexible work?
Does Hainan Huluwa Pharmaceutical Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose the number of employees in R&D functions?
Does Hainan Huluwa Pharmaceutical Group Co Ltd conduct supply chain audits?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Hainan Huluwa Pharmaceutical Group Co Ltd conduct 360 degree staff reviews?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose the individual responsible for D&I?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose current and / or historical scope 2 emissions?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose water use targets?
Does Hainan Huluwa Pharmaceutical Group Co Ltd have careers partnerships with academic institutions?
Did Hainan Huluwa Pharmaceutical Group Co Ltd have a product recall in the last two years?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose incidents of discrimination?
Does Hainan Huluwa Pharmaceutical Group Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Hainan Huluwa Pharmaceutical Group Co Ltd issued a profit warning in the past 24 months?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose parental leave metrics?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose climate scenario or pathway analysis?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose the pay ratio of women to men?
Does Hainan Huluwa Pharmaceutical Group Co Ltd support suppliers with sustainability related research and development?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Hainan Huluwa Pharmaceutical Group Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Hainan Huluwa Pharmaceutical Group Co Ltd involved in embryonic stem cell research?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose GHG and Air Emissions intensity?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose its waste policy?
Does Hainan Huluwa Pharmaceutical Group Co Ltd report according to TCFD requirements?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose energy use targets?
Does Hainan Huluwa Pharmaceutical Group Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Hainan Huluwa Pharmaceutical Group Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Hainan Huluwa Pharmaceutical Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China.